| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT07589244 | A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC | HCC | Recruiting |
| Phase 2 | |||
| NCT07589257 | A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline… | Diffuse Midline Glioma, H3 K27M-Mutant | Recruiting |
| Phase 1/2 | |||
| NCT07093814 | A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma | Glioblastoma | Recruiting |
| Phase 1 | |||
| NCT06046742 | A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors | Solid Tumor | Recruiting |
| NCT06826313 | A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors | Solid Tumors | Recruiting |
| NCT06368921 | A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors | Solid Tumor | Recruiting |